Rosales AM, Castillo FMC

Language: Spanish
References: 13
Page: 74-80
PDF size: 60.70 Kb.

ABSTRACT

Urinalysis is a simple process and quality assurance requires having control in all the phases, from pre-analytic to post-analytic phase. The use of urine control solution is also an official requirement of actual health norms, for which it is important to know its behavior inside clinician laboratory. The principal objective was to know the maximum reproducibility of the values in the constituents of the urine control solution of two commercial brand and two levels of concentration and according to the manufacturing values. This project consisted in try to establishing a protocol of use and handling the same aliquot for a period of six days out of the week. Twenty aliquots of high and normal Bio Rad control level, low and high Kova trol control urine, with the data we established the lab routine values for each constituent and the frequency concentrations values thru the week, we found small variations for some constituents of the two commercials brand, Bio Rad high control level Kova trol presented variations in specific gravity in both levels and leukocytes and erythrocytes of the high level. We conclude that each laboratory needs to establish the stability of urine control in routine work.

REFERENCES

1. Sosa R, Pareja V. Manual de calidad total del urianálisis. México: Roche Diagnósticos; 2001 (no paginado).

2. McBride LJ. Urinalysis and body fluids. New York: Lippincott; 1998. p. 2-12.

3. National Committee for Clinical Laboratory Standards. Clinical laboratory technical 2. Jansen RTP, procedure manuals. 3rd ed. Approved guideline GP2-A3. Wayne, PA. NCCLS; 1996.

4. NCCCLS. Urinalysis collection, transportation and preservation of urine specimens. Approved guideline. NCCCLS. 1995.

5. Guidance for Clinical Laboratory Improvements. Amendenments of 1988 CLIA. Criteria for waiver, guidance for industry and FDA. Draft released for comment on March 2001.

6. Morrison TK. Clinical laboratory and diagnostic test. 3rd ed. California: Appleton & Lange; 1998. p. 155-189.

7. Fernández-Espina C. El aseguramiento de la calidad en el laboratorio clínico. Acta Bioq Clin Latinoam 1999; 33: 46-67.

8. Ben Ezra J, Mc Pherson RA. Evaluation of the Sysmex UF- 100 automated urinalysis analyzer. Clin Chem 1998; 44: 92-95.

9. Comisión de Certificación y Acreditación (Asociación Española de Farmacéuticos Analistas) Manual de calidad tipo para los laboratorios clínicos. Madrid: AEFA; 1998.

10. Toffaleti J, et al. Comparison of 2 automated system for urine chemistry and urine sediment analysis. Lab Hematol 1999; 5: 1-3.

11. Dotson MA. An examination of urine microscopic sediment analysis. Sismex Journal Int 2001; 11: 40-42.

12. Cembrowski GS. The detection of problems analytes in a single proficiency test. Challenge in the absence of the health care financing administration rule violations. Arch Pathol Lab Med 1993; 117: 437-443.

13. Van Leeuwen AM. 6 Steps to building an efficiency tool. Advance Lab 1999; 8: 88-91.